Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology

被引:0
|
作者
Malinauskiene, Vaidota [1 ]
Zuzo, Anastasija [2 ]
Liakina, Valentina [1 ,3 ]
Kazenaite, Edita [1 ]
Stundiene, Ieva [1 ]
机构
[1] Vilnius Univ, Inst Clin Med, Fac Med, Clin Gastroenterol Nephrourol & Surg, 2 Santariskiu Str, LT-01513 Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, LT-01513 Vilnius, Lithuania
[3] Vilnius Tech, Fac Fundamental Sci, Dept Chem & Bioengn, LT-10223 Vilnius, Lithuania
关键词
Menstrual disorders; Inflammatory bowel disease; Adalimumab; Infliximab; Anti-tumor necrosis factor-& alpha; TNF-ALPHA; ENDOMETRIOSIS; EPIDEMIOLOGY; ADALIMUMAB; EXPRESSION; CROHNS; PHASE; PAIN;
D O I
10.12998/wjcc.v11.i21.4989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammatory bowel disease (IBD) is a chronic condition that affects young individuals in their reproductive years. It may have long-term implications on their reproductive, sexual, and mental health. IBD has been related to menstrual abnormalities. Furthermore, the administration of biological therapy can also result in gynecological issues in addition to the disease itself. The purpose of this review was to present potential menstrual cycle problems in patients with IBD, as well as the impact of adalimumab and other anti-tumor necrosis factor medications on gynecological pathology.
引用
收藏
页码:4989 / 4995
页数:7
相关论文
共 50 条
  • [1] Neurotransmitter exchange in cephalalgia in women with gynecological pathology, depending on the stability of the menstrual cycle
    Karakulova, Y.
    Selyanina, N.
    Khasanova, P.
    Ivanova, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 93 - 94
  • [2] Neurotransmitter exchange in cephalalgia in women with gynecological pathology, depending on the stability of the menstrual cycle
    Karakulova, Y.
    Selyanina, N.
    Khasanova, P.
    Ivanova, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 139 - 139
  • [3] BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE
    Sanchez Yanez, E.
    Fuentes Ibanez, M. B.
    Mora Santiago, R.
    ATENCION FARMACEUTICA, 2008, 10 (04): : 234 - 240
  • [4] Biological therapy of inflammatory bowel disease
    Owczarek, Danuta
    Cibor, Dorota
    Szczepanek, Malgorzata
    Mach, Tomasz
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 84 - 88
  • [5] The Effect of the Menstrual Cycle on Inflammatory Bowel Disease: A Prospective Study
    Lim, Sun Min
    Nam, Chung Mo
    Kim, Youn Nam
    Lee, Sin Ae
    Kim, Eun Hye
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    GUT AND LIVER, 2013, 7 (01) : 51 - 57
  • [6] Gastrointestinal symptoms in occurrence with menstrual cycle in young women with inflammatory bowel disease: A complex relationship
    Dilillo, D.
    Penagini, F.
    Cococcioni, L.
    Di Mari, C.
    Sonnino, M.
    Mantegazza, C.
    Fabiano, V.
    Zuccotti, G. V.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (04) : E257 - E258
  • [7] Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle
    Bharadwaj, Shishira
    Barber, Matthew D.
    Graff, Lesley A.
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2015, 3 (03): : 185 - 193
  • [8] Abnormalities of uterine cervix in women with inflammatory bowel disease
    Bhatia, Jyoti
    Bratcher, Jason
    Korelitz, Burton
    Vakher, Katherine
    Mannor, Shlomo
    Shevchuk, Maria
    Panagopoulos, Gworgia
    Ofer, Adam
    Tamas, Ecaterina
    Kotsali, Panayota
    Vele, Oana
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (38) : 6167 - 6171
  • [9] Abnormalities of uterine cervix in women with inflammatory bowel disease
    Jyoti Bhatia
    Jason Bratcher
    Burton Korelitz
    Katherine Vakher
    Shlomo Mannor
    Maria Shevchuk
    Gworgia Panagopoulos
    Adam Ofer
    Ecaterina Tamas
    Panayota Kotsali
    Oana Vele
    World Journal of Gastroenterology, 2006, (38) : 6167 - 6171
  • [10] Biological therapy for chronic inflammatory bowel disease
    Dueker, G.
    Lentze, M. J.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (02) : 118 - 126